Precision Surgery: Intraoperative Molecular Imaging to Improve Margin Detection
In this installment of the NCI Imaging and Informatics Community Webinar, Stanford Cancer Center Medical Director, Dr. Eben Rosenthal, will present how the use of intraoperative molecular imaging (IMI) can help surgeons identify and sample the area on a tumor most likely to contain a tumor-positive margin (the edge of tissue containing cancer cells).
The high rate of tumor-positive margins in head and neck cancer (HNC) are directly correlated with lower survival rates but have remained a gap in the quality of care for these patients for the last 2 decades. Leveraging imaging analysis technology that accurately identifies these margins during surgery has the potential to double the 5-year survival rate of HNC patients.
Dr. Eben Rosenthal is a professor of both otolaryngology and radiology at Stanford. Dr. Rosenthal currently serves as the John and Ann Doerr Medical Director of the Stanford Cancer Center and works collaboratively with the Stanford Cancer Institute and Stanford Health Care leaders to set the strategy for the clinical delivery of cancer care across Stanford Medicine and growing cancer networks.
- HLA Class II Across The Cancer Genome Atlas Cancer DatasetOctober 27, 2021Cloud Computing Workshop: Cancer Genomics Cloud (CGC)October 28, 2021Social Determinants of Health (SDOH)November 03, 2021Cloud Computing Workshop: FireCloudNovember 04, 2021NCI Childhood Cancer Data Initiative Annual Symposium 2021November 09, 2021